July 24th, 2025 – NYC, United States

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) has entered into a definitive agreement to merge with Z Squared, a digital asset mining company focused on Dogecoin (DOGE) and other altcoins. The transaction marks a significant change in direction for Coeptis, which is shifting away from its biopharmaceutical business to focus fully on the cryptocurrency mining sector.

As part of the deal, Coeptis will acquire Z Squared’s large-scale mining operation, including hardware valued at approximately $660 million, hosting agreements across multiple jurisdictions, and proprietary software systems designed to manage energy use and optimize performance in real time.

Dogecoin plays a central role in this pivot. Once known mostly for its origins as a joke, DOGE has since become one of the most visible cryptocurrencies, with a market cap of more than $20 billion and a global user base that remains highly active. For COEP, this visibility—and the volatility that comes with it—offers a chance to participate in an altcoin segment that has often remained out of reach for public market investors.

A Shift from Biotech to Blockchain

Coeptis plans to spin off its biopharma assets into a separate company, allowing its public-facing entity to focus entirely on digital asset infrastructure. Leadership of the combined business will include David Halabu as Chief Executive Officer and Michelle Burke as Chief Operating Officer.

Burke, who previously served as COO of Minting Dome Inc., brings experience in managing international mining logistics and hardware deployment. That experience will be key as the company works across different energy markets and regulatory environments.

Z Squared’s mining strategy is built around flexibility. Rather than relying on a single facility, it partners with hosting providers in multiple regions to take advantage of favorable electricity pricing and local policy conditions. The company’s real-time analytics engine helps it adapt to changing power markets by continuously reallocating hash power and managing power curtailment as needed.

Opening a New Lane in Public Markets

This merger creates a new option for public investors interested in altcoin infrastructure. While most publicly traded mining companies are focused almost entirely on Bitcoin, COEP’s entry into Dogecoin and Litecoin mining offers a different kind of exposure. It’s a niche that has drawn growing interest, but until now has had limited availability in the public market.

Z Squared has also taken steps to address operational pressure points. The company has built internal logistics and repair capabilities that help reduce equipment downtime and extend the lifespan of mining rigs. This approach lowers capital costs and creates a more durable infrastructure in a competitive space where margins can shift quickly.

With this merger, COEP is positioning itself to serve a part of the crypto ecosystem that continues to grow in relevance but has been underserved by public market offerings. The move is both a break from its past and a bet on where digital infrastructure is headed next.

About Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) is a biopharmaceutical and technology company advancing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its pipeline includes clinical-stage and preclinical assets, such as DVX201 and SNAP-CAR, licensed from Deverra Therapeutics and the University of Pittsburgh. In parallel, Coeptis has established a Technology Division focused on operational enhancement through AI-powered marketing and automation tools. Headquartered in Wexford, PA, the company is currently transitioning its business model through a proposed merger with Z Squared to enter the digital asset mining sector.

For more information, users can visit https://coeptistx.com.

Contact

Mike Pell
Phoenix Media
PR@PhoenixMGMTConsulting.com